Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial

Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A government funding notice was added at the top of the page. Related topics (Multiple Myeloma, MedlinePlus Genetics) were added, and the revision tag was updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T08:00:23.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Show glossary was added and metadata labels updated to include Last Update Submitted that Met QC Criteria and Revision: v3.4.0. The term 'Multiple Myeloma' and several related topics (e.g., MedlinePlus Genetics) were removed from the related topics, reflecting a metadata adjustment rather than substantive study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-01-28T05:47:24.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    - Related topics updated: 'Multiple myeloma' is now listed and 'MedlinePlus Genetics' is added under related topics.
    Difference
    0.1%
    Check dated 2026-01-21T05:17:00.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    The top revision badge updated from v3.3.3 to v3.3.4, indicating a minor update.
    Difference
    0.0%
    Check dated 2026-01-14T03:27:51.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    - Removed related topics: 'Multiple myeloma' and 'MedlinePlus Genetics' from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-30T22:45:22.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Locations section now lists New Jersey as the study site. HHS Vulnerability Disclosure link removed and page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:08:27.000Z thumbnail image

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.